Phosphodiesterase‑4 inhibitors: a review of current developments (2013

Phosphodiesterase‑4 inhibitors: a review of current developments (2013–2021)

Published:2022-01-17 Issue:3 Volume:32 Page:261-278
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Liu Zhihao¹,Liu Mingjian¹,Cao Zhenqing¹,Qiu Pengsen¹,Song Gaopeng¹

Affiliation:

1. Key Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Energy, South China Agricultural University, Guangzhou, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2022.2026328

Reference135 articles.

1. Phosphodiesterase-4 as a potential drug target

2. Adenosine 3‘,5‘-Phosphate in Biological Materials

3. Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

4. Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

2. Diaporchalasin A, a new PDE4 inhibitory cytochalasin from Conus marmoreus -derived fungus Diaporthe sp. XMA007;Natural Product Research;2024-06-02

3. Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review;Molecular Biology Reports;2024-04-15

4. Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and¹¹C-Labeled Radioligands That Avoid Radiometabolite Contamination;Journal of Nuclear Medicine;2024-02-29

5. Phosphodiesterase-4 Inhibition in the Management of Psoriasis;Pharmaceutics;2023-12-22